Clinical trial shows biomarkers hold clue in treating aggressive prostate cancer – BioNews Central A Phase 2 clinical trial identified potential reasons for high recurrence rates in aggressive prostate cancer and suggests targeted therapy as a hopeful treatment option. ...

A Phase 2 #ClinicalTrial identified potential reasons for high recurrence rates in #AggressiveProstateCancer and suggests #TargetedTherapy as a hopeful treatment option. 
#ProstateCancer #Biomarkers #ProstateCancerTreatment #Niraparib #ASCO25